Dividend Declaration

RNS Number : 3763Y
Animalcare Group PLC
08 May 2019
 

08 May 2019 

Animalcare Group plc

("Animalcare" or the "Group")

                                                                                                                                                                                    

Dividend declaration for the 12 months ended 31 December 2018

 

Animalcare Group plc (AIM: ANCR), the pan-European Animal Health business, is pleased to announce that, subject to shareholder approval at its Annual General Meeting on Tuesday 25 June 2019, it will pay a final dividend of 2.4 pence per share, adding to the interim dividend of 2.0 pence per share paid in November 2018, giving a total dividend of 4.4 pence per share for the year ended 31 December 2018. The final dividend of 2.4 pence per share will be paid on Friday 5 July 2019 to shareholders whose names are on the Register of Members at close of business on 7 June 2019. The ordinary shares will become ex-dividend on Thursday 6 June 2019.

 

For further information, please contact:

 

Animalcare Group plc

Tel: 01904 487 687

Jenny Winter, Chief Executive Officer

 

Chris Brewster, Chief Financial Officer

 

 

 

Panmure Gordon (UK) Ltd (Nominated Adviser and Broker)

Tel: 020 7886 2500

Corporate Finance

Freddy Crossley / Emma Earl

Corporate Broking

James Stearns

 

 

 

Consilium Strategic Communications

Tel: 020 3709 5700 or animalcare@consilium-comms.com

Amber Fennell

 

Jonathan Birt

 

Angela Gray    

Olivia Manser

 

     

 

About Animalcare (www.Animalcaregroup.co.uk)

Animalcare Group plc is a UK AIM listed veterinary sales and marketing organisation resulting from the merger of Animalcare and Ecuphar NV in July 2017. Animalcare operates in 32 countries in Europe and a further 16 worldwide. The company is focused on bringing new and innovative products to market through its own development pipeline, partnerships and via acquisition.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DIVAPMLTMBJMMJL
UK 100